Chuck Ence - 17 Dec 2021 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
CAO and Compliance Officer
Signature
/s/ Chuck Ence
Issuer symbol
RLMD
Transactions as of
17 Dec 2021
Net transactions value
$0
Form type
4
Filing time
21 Dec 2021, 20:30:33 UTC
Next filing
20 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLMD Stock Option (right to buy) Award $0 +226,832 $0.000000 226,832 17 Dec 2021 Common Stock 226,832 $19.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 16 equal quarterly installments commencing on March 17, 2022.